Cargando…

Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection

SARS-CoV-2 infection rapidly elicits anti-Spike antibodies whose quantity in plasma gradually declines upon resolution of symptoms. This decline is part of the evolution of an immune response leading to B cell differentiation into short-lived antibody-secreting cells or resting memory B cells. At th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tauzin, Alexandra, Gendron-Lepage, Gabrielle, Nayrac, Manon, Anand, Sai Priya, Bourassa, Catherine, Medjahed, Halima, Goyette, Guillaume, Dubé, Mathieu, Bazin, Renée, Kaufmann, Daniel E., Finzi, Andrés
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949389/ https://www.ncbi.nlm.nih.gov/pubmed/35336940 http://dx.doi.org/10.3390/v14030532

Ejemplares similares

Temsavir Modulates HIV-1 Envelope Conformation by Decreasing Its Proteolytic Cleavage
por: Boutin, Marianne, et al.
Publicado: (2023)

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
por: Anand, Sai Priya, et al.
Publicado: (2021)

Humoral Responses Elicited after a Fifth Dose of SARS-CoV-2 mRNA Bivalent Vaccine
por: Tauzin, Alexandra, et al.
Publicado: (2023)

Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
por: Boutin, Marianne, et al.
Publicado: (2022)

Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes
por: Chatterjee, Debashree, et al.
Publicado: (2022)

A Recent SARS-CoV-2 Infection Enhances Antibody-Dependent Cellular Cytotoxicity against Several Omicron Subvariants following a Fourth mRNA Vaccine Dose
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2023)

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
por: Nayrac, Manon, et al.
Publicado: (2021)

Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity
por: Gong, Shang Yu, et al.
Publicado: (2021)

SARS-CoV-2 Accessory Protein ORF8 Decreases Antibody-Dependent Cellular Cytotoxicity
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2022)

Humoral Responses against BQ.1.1 Elicited after Breakthrough Infection and SARS-CoV-2 mRNA Vaccination
por: Tauzin, Alexandra, et al.
Publicado: (2023)

An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells
por: Nicolas, Alexandre, et al.
Publicado: (2022)

Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
por: Tauzin, Alexandra, et al.
Publicado: (2022)

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
por: Nayrac, Manon, et al.
Publicado: (2022)

Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
por: Tauzin, Alexandra, et al.
Publicado: (2023)

A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
por: Tauzin, Alexandra, et al.
Publicado: (2021)

Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV
por: Marchitto, Lorie, et al.
Publicado: (2023)

Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients
por: Tauzin, Alexandra, et al.
Publicado: (2022)

Impact of HIV-1 Vpu-mediated downregulation of CD48 on NK-cell-mediated antibody-dependent cellular cytotoxicity
por: Marchitto, Lorie, et al.
Publicado: (2023)

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4(+) T cell profile
por: Sannier, Gérémy, et al.
Publicado: (2023)

SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
por: Chatterjee, Debashree, et al.
Publicado: (2022)

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2020)

SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells
por: Ding, Shilei, et al.
Publicado: (2021)

A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
por: Tauzin, Alexandra, et al.
Publicado: (2022)

Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality
por: Brunet-Ratnasingham, Elsa, et al.
Publicado: (2021)

Avidity of IgG to SARS-CoV-2 RBD as a Prognostic Factor for the Severity of COVID-19 Reinfection
por: Manuylov, Victor, et al.
Publicado: (2022)

Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses
por: Prévost, Jérémie, et al.
Publicado: (2019)

Across Functional Boundaries: Making Nonneutralizing Antibodies To Neutralize HIV-1 and Mediate Fc-Mediated Effector Killing of Infected Cells
por: Richard, Jonathan, et al.
Publicado: (2021)

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset
por: Perreault, Josée, et al.
Publicado: (2020)

HIV-1 Vpu restricts Fc-mediated effector functions in vivo
por: Prévost, Jérémie, et al.
Publicado: (2022)

Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike
por: Prévost, Jérémie, et al.
Publicado: (2020)

Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
por: Ding, Shilei, et al.
Publicado: (2020)

RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2
por: da Costa, Hernan H. M., et al.
Publicado: (2023)

Piperidine CD4-mimetic compounds expose vulnerable Env epitopes sensitizing HIV-1-infected cells to ADCC
por: Ding, Shilei, et al.
Publicado: (2023)

HIV-1 Envelope Glycoprotein Cell Surface Localization Is Associated with Antibody-Induced Internalization
por: Anand, Sai Priya, et al.
Publicado: (2021)

Serological IgG avidity test for ocular toxoplasmosis
por: Suresh, Subramaniam, et al.
Publicado: (2012)

Significance of IgG-Avidity in Antenatal Rubella Diagnosis
por: Agbede, Olajide Olubunmi, et al.
Publicado: (2013)

Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC
por: Ding, Shilei, et al.
Publicado: (2023)

Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2
por: Gong, Shang Yu, et al.
Publicado: (2022)

IgG Avidity Test in Congenital Toxoplasmosis Diagnoses in Newborns
por: Cardoso Fonseca, Zulmirene, et al.
Publicado: (2017)

Nanoscale spatial dependence of avidity in an IgG1 antibody
por: Jendroszek, Agnieszka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kmsfli1hbu9cdpai5lj23qufig